カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のポルフィリン症治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Porphyrias Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19558）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19558
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のポルフィリン症治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ポルフィリン症治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のポルフィリン症治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ポルフィリン症治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経口、注射

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局

世界のポルフィリン症治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Lundbeck、Recordati Rare Diseases、Teva Pharmaceutical、Apotex

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ポルフィリン症治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なポルフィリン症治療薬メーカーの企業概要、2019年～2022年までのポルフィリン症治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なポルフィリン症治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ポルフィリン症治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのポルフィリン症治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのポルフィリン症治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびポルフィリン症治療薬の産業チェーンを掲載しています。
・第13、14、15章では、ポルフィリン症治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ポルフィリン症治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：経口、注射
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
- 世界のポルフィリン症治療薬市場規模・予測
- 世界のポルフィリン症治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Lundbeck、Recordati Rare Diseases、Teva Pharmaceutical、Apotex
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経口、注射
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
・ポルフィリン症治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ポルフィリン症治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ポルフィリン症治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ポルフィリン症治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ポルフィリン症治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Porphyrias Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Porphyrias Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Porphyrias Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Porphyrias Drugs include Lundbeck, Recordati Rare Diseases, Teva Pharmaceutical, Apotex, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Porphyrias Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injectable
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Porphyrias Drugs market are listed below:
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porphyrias Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Porphyrias Drugs, with price, sales, revenue and global market share of Porphyrias Drugs from 2019 to 2022.
Chapter 3, the Porphyrias Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porphyrias Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Porphyrias Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Porphyrias Drugs.
Chapter 13, 14, and 15, to describe Porphyrias Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Porphyrias Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Porphyrias Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Porphyrias Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Porphyrias Drugs Market Size & Forecast
1.4.1 Global Porphyrias Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Porphyrias Drugs Sales in Volume (2017-2028)
1.4.3 Global Porphyrias Drugs Price (2017-2028)
1.5 Global Porphyrias Drugs Production Capacity Analysis
1.5.1 Global Porphyrias Drugs Total Production Capacity (2017-2028)
1.5.2 Global Porphyrias Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Porphyrias Drugs Market Drivers
1.6.2 Porphyrias Drugs Market Restraints
1.6.3 Porphyrias Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Lundbeck
2.1.1 Lundbeck Details
2.1.2 Lundbeck Major Business
2.1.3 Lundbeck Porphyrias Drugs Product and Services
2.1.4 Lundbeck Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Recordati Rare Diseases
2.2.1 Recordati Rare Diseases Details
2.2.2 Recordati Rare Diseases Major Business
2.2.3 Recordati Rare Diseases Porphyrias Drugs Product and Services
2.2.4 Recordati Rare Diseases Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Porphyrias Drugs Product and Services
2.3.4 Teva Pharmaceutical Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business
2.4.3 Apotex Porphyrias Drugs Product and Services
2.4.4 Apotex Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Porphyrias Drugs Breakdown Data by Manufacturer
3.1 Global Porphyrias Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Porphyrias Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Porphyrias Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Porphyrias Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Porphyrias Drugs Manufacturer Market Share in 2021
3.5 Global Porphyrias Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Porphyrias Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Porphyrias Drugs Market Size by Region
4.1.1 Global Porphyrias Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Porphyrias Drugs Revenue by Region (2017-2028)
4.2 North America Porphyrias Drugs Revenue (2017-2028)
4.3 Europe Porphyrias Drugs Revenue (2017-2028)
4.4 Asia-Pacific Porphyrias Drugs Revenue (2017-2028)
4.5 South America Porphyrias Drugs Revenue (2017-2028)
4.6 Middle East and Africa Porphyrias Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Porphyrias Drugs Sales in Volume by Type (2017-2028)
5.2 Global Porphyrias Drugs Revenue by Type (2017-2028)
5.3 Global Porphyrias Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Porphyrias Drugs Sales in Volume by Application (2017-2028)
6.2 Global Porphyrias Drugs Revenue by Application (2017-2028)
6.3 Global Porphyrias Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Porphyrias Drugs Sales by Type (2017-2028)
7.2 North America Porphyrias Drugs Sales by Application (2017-2028)
7.3 North America Porphyrias Drugs Market Size by Country
7.3.1 North America Porphyrias Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Porphyrias Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Porphyrias Drugs Sales by Type (2017-2028)
8.2 Europe Porphyrias Drugs Sales by Application (2017-2028)
8.3 Europe Porphyrias Drugs Market Size by Country
8.3.1 Europe Porphyrias Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Porphyrias Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Porphyrias Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Porphyrias Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Porphyrias Drugs Market Size by Region
9.3.1 Asia-Pacific Porphyrias Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Porphyrias Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Porphyrias Drugs Sales by Type (2017-2028)
10.2 South America Porphyrias Drugs Sales by Application (2017-2028)
10.3 South America Porphyrias Drugs Market Size by Country
10.3.1 South America Porphyrias Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Porphyrias Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Porphyrias Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Porphyrias Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Porphyrias Drugs Market Size by Country
11.3.1 Middle East & Africa Porphyrias Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Porphyrias Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Porphyrias Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Porphyrias Drugs
12.3 Porphyrias Drugs Production Process
12.4 Porphyrias Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Porphyrias Drugs Typical Distributors
13.3 Porphyrias Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Porphyrias Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Porphyrias Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 4. Lundbeck Major Business
Table 5. Lundbeck Porphyrias Drugs Product and Services
Table 6. Lundbeck Porphyrias Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Recordati Rare Diseases Basic Information, Manufacturing Base and Competitors
Table 8. Recordati Rare Diseases Major Business
Table 9. Recordati Rare Diseases Porphyrias Drugs Product and Services
Table 10. Recordati Rare Diseases Porphyrias Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Major Business
Table 13. Teva Pharmaceutical Porphyrias Drugs Product and Services
Table 14. Teva Pharmaceutical Porphyrias Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Apotex Basic Information, Manufacturing Base and Competitors
Table 16. Apotex Major Business
Table 17. Apotex Porphyrias Drugs Product and Services
Table 18. Apotex Porphyrias Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Porphyrias Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Porphyrias Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Porphyrias Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Porphyrias Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Porphyrias Drugs Production Site of Key Manufacturer
Table 24. Porphyrias Drugs New Entrant and Capacity Expansion Plans
Table 25. Porphyrias Drugs Mergers & Acquisitions in the Past Five Years
Table 26. Global Porphyrias Drugs Sales by Region (2017-2022) & (K Units)
Table 27. Global Porphyrias Drugs Sales by Region (2023-2028) & (K Units)
Table 28. Global Porphyrias Drugs Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Porphyrias Drugs Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Porphyrias Drugs Sales by Type (2017-2022) & (K Units)
Table 31. Global Porphyrias Drugs Sales by Type (2023-2028) & (K Units)
Table 32. Global Porphyrias Drugs Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Porphyrias Drugs Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Porphyrias Drugs Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Porphyrias Drugs Price by Type (2023-2028) & (USD/Unit)
Table 36. Global Porphyrias Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Porphyrias Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Porphyrias Drugs Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Porphyrias Drugs Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Porphyrias Drugs Price by Application (2017-2022) & (USD/Unit)
Table 41. Global Porphyrias Drugs Price by Application (2023-2028) & (USD/Unit)
Table 42. North America Porphyrias Drugs Sales by Country (2017-2022) & (K Units)
Table 43. North America Porphyrias Drugs Sales by Country (2023-2028) & (K Units)
Table 44. North America Porphyrias Drugs Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Porphyrias Drugs Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Porphyrias Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Porphyrias Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Porphyrias Drugs Sales by Application (2017-2022) & (K Units)
Table 49. North America Porphyrias Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Europe Porphyrias Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Porphyrias Drugs Sales by Country (2023-2028) & (K Units)
Table 52. Europe Porphyrias Drugs Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Porphyrias Drugs Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Porphyrias Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Porphyrias Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Europe Porphyrias Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Porphyrias Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Porphyrias Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Porphyrias Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Porphyrias Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Porphyrias Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Porphyrias Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Porphyrias Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Porphyrias Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Porphyrias Drugs Sales by Application (2023-2028) & (K Units)
Table 66. South America Porphyrias Drugs Sales by Country (2017-2022) & (K Units)
Table 67. South America Porphyrias Drugs Sales by Country (2023-2028) & (K Units)
Table 68. South America Porphyrias Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Porphyrias Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Porphyrias Drugs Sales by Type (2017-2022) & (K Units)
Table 71. South America Porphyrias Drugs Sales by Type (2023-2028) & (K Units)
Table 72. South America Porphyrias Drugs Sales by Application (2017-2022) & (K Units)
Table 73. South America Porphyrias Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Porphyrias Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Porphyrias Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Porphyrias Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Porphyrias Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Porphyrias Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Porphyrias Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Porphyrias Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Porphyrias Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Porphyrias Drugs Raw Material
Table 83. Key Manufacturers of Porphyrias Drugs Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Porphyrias Drugs Typical Distributors
Table 87. Porphyrias Drugs Typical Customers
List of Figures
Figure 1. Porphyrias Drugs Picture
Figure 2. Global Porphyrias Drugs Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Injectable
Figure 5. Global Porphyrias Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Porphyrias Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Porphyrias Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Porphyrias Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Porphyrias Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Porphyrias Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Porphyrias Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Porphyrias Drugs Market Drivers
Figure 16. Porphyrias Drugs Market Restraints
Figure 17. Porphyrias Drugs Market Trends
Figure 18. Global Porphyrias Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Porphyrias Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Porphyrias Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Porphyrias Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Porphyrias Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Porphyrias Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Porphyrias Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Porphyrias Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Porphyrias Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Porphyrias Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Porphyrias Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Porphyrias Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Porphyrias Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Porphyrias Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Porphyrias Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Porphyrias Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Porphyrias Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Porphyrias Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Porphyrias Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Porphyrias Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Porphyrias Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Porphyrias Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Porphyrias Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Porphyrias Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Porphyrias Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Porphyrias Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Porphyrias Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Porphyrias Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Porphyrias Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Porphyrias Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Porphyrias Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Porphyrias Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Porphyrias Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Porphyrias Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Porphyrias Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Porphyrias Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Porphyrias Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Porphyrias Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Porphyrias Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Porphyrias Drugs in 2021
Figure 77. Manufacturing Process Analysis of Porphyrias Drugs
Figure 78. Porphyrias Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19558 )"世界のポルフィリン症治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Porphyrias Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。